Genome & Company (KOSDAQ:314130)

South Korea · Delayed Price · Currency is KRW

4,015.00

-205.00 (-4.86%)

At close: Oct 22, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Pharmaceuticals	24.59B	27.74B	14.30B	14.08B	451.25M
Total	24.59B	27.74B	14.30B	14.08B	451.25M

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
South Korea	13.37B	6.30B	2.39B	14.08B	451.25M
Asia	5.95B	4.43B	7.19B	-	-
Europe	785.01M	7.37B	269.13M	-	-
South America	31.13M	29.46M	15.04M	-	-
North America	4.44B	9.60B	4.39B	-	-
Oceania	13.71M	10.97M	52.16M	-	-
Total	24.59B	27.74B	14.30B	14.08B	451.25M